Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Miszczyk

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
BJU International|March 16, 2026
Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysisNavid Roessler, Marcin Miszczyk, Paolo Gontero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR): A STOPSTORM.eu consortium studyLuuk H G van der Pol, Oliver Blanck, Melanie Grehn, et al.
Urologic Oncology|October 8, 2024
The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysisIchiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
Cancers|January 25, 2025
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate CancerAkihiro Matsukawa, Giulio Litterio, Angelo Cormio, et al.
Clinical Genitourinary Cancer|November 15, 2024
The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
European Urology Open Science|September 25, 2025
Impact of PARP Inhibitors on Health-related Quality of Life in Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysisNavid Roessler, Marcin Miszczyk, Akihiro Matsukawa, et al.
BMC Urology|April 28, 2025
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Urologic Oncology|December 13, 2025
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysisIchiro Tsuboi, Pawel Rajwa, Marcin Miszczyk, et al.
Expert Review of Molecular Diagnostics|October 9, 2025
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlookShota Inoue, Marcin Miszczyk, Agata Suleja, et al.
European Urology Oncology|October 16, 2024
Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic ReviewTamás Fazekas, Maximilian Pallauf, Jakub Kufel, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
BJU International|March 16, 2026
Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysisNavid Roessler, Marcin Miszczyk, Paolo Gontero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR): A STOPSTORM.eu consortium studyLuuk H G van der Pol, Oliver Blanck, Melanie Grehn, et al.
Urologic Oncology|October 8, 2024
The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysisIchiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
Cancers|January 25, 2025
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate CancerAkihiro Matsukawa, Giulio Litterio, Angelo Cormio, et al.
Clinical Genitourinary Cancer|November 15, 2024
The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
European Urology Open Science|September 25, 2025
Impact of PARP Inhibitors on Health-related Quality of Life in Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysisNavid Roessler, Marcin Miszczyk, Akihiro Matsukawa, et al.
BMC Urology|April 28, 2025
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Urologic Oncology|December 13, 2025
Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysisIchiro Tsuboi, Pawel Rajwa, Marcin Miszczyk, et al.
Expert Review of Molecular Diagnostics|October 9, 2025
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlookShota Inoue, Marcin Miszczyk, Agata Suleja, et al.
European Urology Oncology|October 16, 2024
Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic ReviewTamás Fazekas, Maximilian Pallauf, Jakub Kufel, et al.
Pageof 14